Notably, the proportion of LAG-3+TIM-3hi NK cells was increased from the 3rd month to 4th month after the initial AOM administration (Fig. 2C), suggesting an increase in exhausted NK cells during CRC development. The gene discussed is LAG3; the disease is colorectal carcinoma.